Latest News

Thursday, October 12, 2017 | Medical Studies

Report: Lutein & Zeaxanthin Supplementation Could Save EU Billions in Healthcare Costs Associated with AMD

A new study produced by Frost & Sullivan has found that savings of €6.20 billion ($7.33 billion) a year could be generated through the daily consumption of 10 mg of lutein and 2 mg of ze…

Read the full story

Thursday, October 12, 2017 | Cataract Surgery,FDA Approval/Clearance

ARC Laser Receives FDA Approval for Cetus Nano-Laser System

ARC Laser recently received FDA approval for the use of the Cetus Nano-Laser system in cataract surgery. The Cetus system includes a base that houses the laser with a touch-screen to adjust the laser …

Read the full story

Thursday, October 12, 2017 | Miscellaneous

Sheraz Daya Featured in BBC Documentary

Sheraz Daya, MD FACP FACS FRCS(Ed) FRCOphth, Ophthalmologist and Medical Director of Centre for Sight in the UK, has been featured in a BBC Documentary about the practices and regulation of laser eye …

Read the full story

Wednesday, October 11, 2017 | Earnings & Financials

Azura Ophthalmics Receives $16 Million in Series B Funding to Develop Treatment for Leading Cause of Dry Eye Disease

Azura Ophthalmics announced it has completed a $16 million Series B funding that will enable Azura to advance development of drug therapy for meibomian gland dysfunction (MGD) to the next stage o…

Read the full story

Wednesday, October 11, 2017 | Glaucoma, Aerie Pharmaceuticals

Aerie Climbs After FDA Briefing Concurs With Efficacy Claims

Aerie Pharmaceuticals has received good news going into its FDA advisory committee meeting. The FDA agreed with the efficacy conclusion Aerie reached to support its bid for approval of glaucoma and oc…

Read the full story

Wednesday, October 11, 2017 | Medical Studies, Alcon

New Data Shows Astigmatism Tends to Worsen Following Cataract Surgery With a Standard Monofocal IOL

Alcon presented a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery, and results from the "More to See" survey that reveal a widespread la…

Read the full story

Wednesday, October 11, 2017 | Conferences, Bio-Tissue

Bio-Tissue Announces Availability of New Prokera Medical Coding And Compliance Guide at American Academy of Optometry’s Annual Meeting

Bio-Tissue, a business unit of TissueTech, announced a new Prokera Medical Coding and Compliance Guide is now available for practitioners. The new guide will be introduced and available at the upcomin…

Read the full story

Wednesday, October 11, 2017 | Clinical Trials,Medical Studies, Spark Therapeutics

Spark Gene Therapy Improves Vision, At Least in Short Term: FDA

Spark Therapeutics’s experimental gene therapy for a rare inherited form of blindness improves vision, though it is unclear whether the benefit lasts over time, according to a preliminary review…

Read the full story

Wednesday, October 11, 2017 | Earnings & Financials

Biophytis Completes a €10.4 M Capital Increase to Finance Mid-Stage Clinical Trials for Two Anti-Aging Drug-Candidates

Biophytis announced entry into definitive agreements for a €10.4 million capital raise to fund the its clinical development in age-related diseases, such as Sarcopenia and dry age-related macular…

Read the full story

Tuesday, October 10, 2017 | Conferences,Medical Studies, Alcon

Data Presentations at ESCRS on Astigmatism, CyPass, and AcrySof IOLs

Alcon will present a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery, and results from the “More to See” survey that reveal a widespre…

Read the full story

Tuesday, October 10, 2017 | Glaucoma,Partnerships, Nicox , Psivida

Nicox and pSivida Enter Strategic Collaboration Agreement to Develop Sustained-Release Drug to Lower Intraocular Pressure in Patients with Glaucoma

Nicox and pSivida announced their entry into a collaboration agreement to explore the potential of combining Nicox's nitric oxide (NO)-donating compounds with pSivida's bioerodible sustained-r…

Read the full story

Tuesday, October 10, 2017 | Milestones

California Optometric Association Champions Bill to Expand Optometric Practice in California

Over the weekend, Governor Jerry Brown signed AB 443, a bill championed by the California Optometric Association (COA) to improve eye care access for Californians. The bill, authored by Assembly Membe…

Read the full story

Tuesday, October 10, 2017 | Clinical Trials,Medical Studies,Retina, ThromboGenics

ThromboGenics Announces Publication in Experimental Eye Research of Preclinical Data Supporting Therapeutic Potential of THR-317 in DR

ThromboGenics NV announced that preclinical data on its THR-317 have been published in Experimental Eye Research. ThromboGenics’ preclinical studies are designed to investigate inhibition of pla…

Read the full story

Sunday, October 08, 2017 | Medical Studies

Large European Study Highlights Benefit of Combination Treatment to Prevent Cystoid Macular Edema

A combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either agent alone in reducing the risk of developing cystoid macular edema (CME) aft…

Read the full story

Saturday, October 07, 2017 | Product Releases, Johnson & Johnson Vision Care

Johnson & Johnson Vision Introduces iDESIGN Refractive Studio at ESCRS

Johnson & Johnson Vision announced the CE mark of its new iDESIGN Refractive Studio, which integrates corneal topography measurements into the current wavefront-guided treatment to deliver th…

Read the full story
Load More
 Stock Price  Change 
 ADVM $3.48  2.21% 
 Aerie Pharmaceuticals, Inc. $65.10  0.39% 
 Akorn, Inc. $33.28  0.39% 
 Alimera Sciences, Inc. $1.38  0.00% 
 Allergan $188.28  -0.52% 
 Applied Genetic Technologies $4.05  3.85% 
 Avalanche Biotechnologies $0.00  0.00% 
 Bayer $34.80  -1.16% 
 Can-Fite Biopharma $1.65  -0.60% 
 Carl Zeiss Meditec $44.87  -0.29% 
 Clearside Biomedical $7.90  0.13% 
 Cooper Companies, Inc. $235.35  -0.31% 
 Eleven Biotherapeutics $1.30  0.78% 
 Escalon Medical Corp. $0.14  7.69% 
 Essilor International $101.05  -0.44% 
 Glaukos $33.62  2.72% 
 Imprimis Pharmaceuticals, Inc. $1.85  -1.60% 
 Inotek Pharmaceuticals $2.38  2.15% 
 IRIDEX Corporation $9.52  -0.10% 
 Johnson & Johnson $142.40  0.25% 
 Luxottica Group, S.p.A. $60.90  0.41% 
 Merck & Company, Inc. $63.88  0.20% 
 NicOx $8.97  0.78% 
 NovaBay Pharmaceuticals, Inc. $4.30  -3.37% 
 Novartis AG Common Stock $85.74  -0.49% 
 Ocular Therapeutix $5.56  -1.24% 
 Ophthotech Corporation $2.41  -1.63% 
 QLT $1.95  0.00% 
 Quantel $7.06  -0.42% 
 Regeneron $432.98  -1.81% 
 Roche $29.73  -2.27% 
 Second Sight Medical Products $1.14  0.00% 
 Shire $145.25  -1.74% 
 Spark Therapeutics, Inc. $81.87  1.34% 
 STAAR Surgical Company $12.95  4.02% 
 TearLab Corporation $1.30  0.00% 
 Thrombogenics $5.01  -4.97% 
 Valeant Pharmaceuticals $12.13  -2.80% 
 Xoma $22.65  -2.66%